Global Untargeted Metabolomics Market Growth (Status and Outlook) 2026-2032
The global Untargeted Metabolomics market size is predicted to grow from US$ 1620 million in 2025 to US$ 3156 million in 2032; it is expected to grow at a CAGR of 10.2% from 2026 to 2032.
Untargeted metabolomics is a study in which all detectable metabolites are identified and quantitated for analyzing the overall metabolic characteristics and discovering metabolic mechanisms behind the phenomenon. Also known as discovery metabolomics, untargeted metabolomics is a powerful tool for large-scale early phase diagnosis and discovery of new biomarkers. Compared to traditional metabolic quantitation methods, untargeted metabolomics is a high-throughput technology, enabling more comprehensive analysis with more accurate data acquisition, eliminating biased research direction.
United States market for Untargeted Metabolomics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Untargeted Metabolomics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Untargeted Metabolomics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Untargeted Metabolomics players cover Creative Proteomics, Metabolon, Alfa Chemistry, Novelgene Technologies, MtoZ-Biolabs Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Untargeted Metabolomics Industry Forecast? looks at past sales and reviews total world Untargeted Metabolomics sales in 2025, providing a comprehensive analysis by region and market sector of projected Untargeted Metabolomics sales for 2026 through 2032. With Untargeted Metabolomics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Untargeted Metabolomics industry.
This Insight Report provides a comprehensive analysis of the global Untargeted Metabolomics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Untargeted Metabolomics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Untargeted Metabolomics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Untargeted Metabolomics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Untargeted Metabolomics.
This report presents a comprehensive overview, market shares, and growth opportunities of Untargeted Metabolomics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Untargeted metabolomics is a study in which all detectable metabolites are identified and quantitated for analyzing the overall metabolic characteristics and discovering metabolic mechanisms behind the phenomenon. Also known as discovery metabolomics, untargeted metabolomics is a powerful tool for large-scale early phase diagnosis and discovery of new biomarkers. Compared to traditional metabolic quantitation methods, untargeted metabolomics is a high-throughput technology, enabling more comprehensive analysis with more accurate data acquisition, eliminating biased research direction.
United States market for Untargeted Metabolomics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Untargeted Metabolomics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Untargeted Metabolomics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Untargeted Metabolomics players cover Creative Proteomics, Metabolon, Alfa Chemistry, Novelgene Technologies, MtoZ-Biolabs Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Untargeted Metabolomics Industry Forecast? looks at past sales and reviews total world Untargeted Metabolomics sales in 2025, providing a comprehensive analysis by region and market sector of projected Untargeted Metabolomics sales for 2026 through 2032. With Untargeted Metabolomics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Untargeted Metabolomics industry.
This Insight Report provides a comprehensive analysis of the global Untargeted Metabolomics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Untargeted Metabolomics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Untargeted Metabolomics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Untargeted Metabolomics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Untargeted Metabolomics.
This report presents a comprehensive overview, market shares, and growth opportunities of Untargeted Metabolomics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Plant Untargeted Metabolomics
- Human Untargeted Metabolomics
- Other
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Creative Proteomics
- Metabolon
- Alfa Chemistry
- Novelgene Technologies
- MtoZ-Biolabs Inc.
- CD Genomics
- Metware Biotechnology Inc (Metware)
- BGI Genomics
- APPLIED PROTEIN TECHNOLOGY
- Suzhou PANOMIX Biomedical Tech Co.,Ltd
- OBiO Technology ( Shanghai ) Corp.,Ltd.
- Beijing Huayi innovation & BioTechnology Co., Ltd
- Abace Biotechnology
- Metabo-Profile
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Untargeted Metabolomics Market Size (2021-2032)
2.1.2 Untargeted Metabolomics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Untargeted Metabolomics by Country/Region (2021, 2025 & 2032)
2.2 Untargeted Metabolomics Segment by Type
2.2.1 Plant Untargeted Metabolomics
2.2.2 Human Untargeted Metabolomics
2.2.3 Other
2.2.4 Untargeted Metabolomics Market Size by Type
2.2.4.1 Untargeted Metabolomics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Untargeted Metabolomics Market Size Market Share by Type (2021-2026)
2.3 Untargeted Metabolomics Segment by Application
2.3.1 Academic and Research Institutions
2.3.2 Pharmaceutical and Biotechnology Companies
2.3.3 Untargeted Metabolomics Market Size by Application
2.3.3.1 Untargeted Metabolomics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Untargeted Metabolomics Market Size Market Share by Application (2021-2026)
3 UNTARGETED METABOLOMICS MARKET SIZE BY PLAYER
3.1 Untargeted Metabolomics Market Size Market Share by Player
3.1.1 Global Untargeted Metabolomics Revenue by Player (2021-2026)
3.1.2 Global Untargeted Metabolomics Revenue Market Share by Player (2021-2026)
3.2 Global Untargeted Metabolomics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 UNTARGETED METABOLOMICS BY REGION
4.1 Untargeted Metabolomics Market Size by Region (2021-2026)
4.2 Global Untargeted Metabolomics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Untargeted Metabolomics Market Size Growth (2021-2026)
4.4 APAC Untargeted Metabolomics Market Size Growth (2021-2026)
4.5 Europe Untargeted Metabolomics Market Size Growth (2021-2026)
4.6 Middle East & Africa Untargeted Metabolomics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Untargeted Metabolomics Market Size by Country (2021-2026)
5.2 Americas Untargeted Metabolomics Market Size by Type (2021-2026)
5.3 Americas Untargeted Metabolomics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Untargeted Metabolomics Market Size by Region (2021-2026)
6.2 APAC Untargeted Metabolomics Market Size by Type (2021-2026)
6.3 APAC Untargeted Metabolomics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Untargeted Metabolomics Market Size by Country (2021-2026)
7.2 Europe Untargeted Metabolomics Market Size by Type (2021-2026)
7.3 Europe Untargeted Metabolomics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Untargeted Metabolomics by Region (2021-2026)
8.2 Middle East & Africa Untargeted Metabolomics Market Size by Type (2021-2026)
8.3 Middle East & Africa Untargeted Metabolomics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL UNTARGETED METABOLOMICS MARKET FORECAST
10.1 Global Untargeted Metabolomics Forecast by Region (2027-2032)
10.1.1 Global Untargeted Metabolomics Forecast by Region (2027-2032)
10.1.2 Americas Untargeted Metabolomics Forecast
10.1.3 APAC Untargeted Metabolomics Forecast
10.1.4 Europe Untargeted Metabolomics Forecast
10.1.5 Middle East & Africa Untargeted Metabolomics Forecast
10.2 Americas Untargeted Metabolomics Forecast by Country (2027-2032)
10.2.1 United States Market Untargeted Metabolomics Forecast
10.2.2 Canada Market Untargeted Metabolomics Forecast
10.2.3 Mexico Market Untargeted Metabolomics Forecast
10.2.4 Brazil Market Untargeted Metabolomics Forecast
10.3 APAC Untargeted Metabolomics Forecast by Region (2027-2032)
10.3.1 China Untargeted Metabolomics Market Forecast
10.3.2 Japan Market Untargeted Metabolomics Forecast
10.3.3 Korea Market Untargeted Metabolomics Forecast
10.3.4 Southeast Asia Market Untargeted Metabolomics Forecast
10.3.5 India Market Untargeted Metabolomics Forecast
10.3.6 Australia Market Untargeted Metabolomics Forecast
10.4 Europe Untargeted Metabolomics Forecast by Country (2027-2032)
10.4.1 Germany Market Untargeted Metabolomics Forecast
10.4.2 France Market Untargeted Metabolomics Forecast
10.4.3 UK Market Untargeted Metabolomics Forecast
10.4.4 Italy Market Untargeted Metabolomics Forecast
10.4.5 Russia Market Untargeted Metabolomics Forecast
10.5 Middle East & Africa Untargeted Metabolomics Forecast by Region (2027-2032)
10.5.1 Egypt Market Untargeted Metabolomics Forecast
10.5.2 South Africa Market Untargeted Metabolomics Forecast
10.5.3 Israel Market Untargeted Metabolomics Forecast
10.5.4 Turkey Market Untargeted Metabolomics Forecast
10.6 Global Untargeted Metabolomics Forecast by Type (2027-2032)
10.7 Global Untargeted Metabolomics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Untargeted Metabolomics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Creative Proteomics
11.1.1 Creative Proteomics Company Information
11.1.2 Creative Proteomics Untargeted Metabolomics Product Offered
11.1.3 Creative Proteomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Creative Proteomics Main Business Overview
11.1.5 Creative Proteomics Latest Developments
11.2 Metabolon
11.2.1 Metabolon Company Information
11.2.2 Metabolon Untargeted Metabolomics Product Offered
11.2.3 Metabolon Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Metabolon Main Business Overview
11.2.5 Metabolon Latest Developments
11.3 Alfa Chemistry
11.3.1 Alfa Chemistry Company Information
11.3.2 Alfa Chemistry Untargeted Metabolomics Product Offered
11.3.3 Alfa Chemistry Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Alfa Chemistry Main Business Overview
11.3.5 Alfa Chemistry Latest Developments
11.4 Novelgene Technologies
11.4.1 Novelgene Technologies Company Information
11.4.2 Novelgene Technologies Untargeted Metabolomics Product Offered
11.4.3 Novelgene Technologies Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Novelgene Technologies Main Business Overview
11.4.5 Novelgene Technologies Latest Developments
11.5 MtoZ-Biolabs Inc.
11.5.1 MtoZ-Biolabs Inc. Company Information
11.5.2 MtoZ-Biolabs Inc. Untargeted Metabolomics Product Offered
11.5.3 MtoZ-Biolabs Inc. Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 MtoZ-Biolabs Inc. Main Business Overview
11.5.5 MtoZ-Biolabs Inc. Latest Developments
11.6 CD Genomics
11.6.1 CD Genomics Company Information
11.6.2 CD Genomics Untargeted Metabolomics Product Offered
11.6.3 CD Genomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 CD Genomics Main Business Overview
11.6.5 CD Genomics Latest Developments
11.7 Metware Biotechnology Inc (Metware)
11.7.1 Metware Biotechnology Inc (Metware) Company Information
11.7.2 Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product Offered
11.7.3 Metware Biotechnology Inc (Metware) Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Metware Biotechnology Inc (Metware) Main Business Overview
11.7.5 Metware Biotechnology Inc (Metware) Latest Developments
11.8 BGI Genomics
11.8.1 BGI Genomics Company Information
11.8.2 BGI Genomics Untargeted Metabolomics Product Offered
11.8.3 BGI Genomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 BGI Genomics Main Business Overview
11.8.5 BGI Genomics Latest Developments
11.9 APPLIED PROTEIN TECHNOLOGY
11.9.1 APPLIED PROTEIN TECHNOLOGY Company Information
11.9.2 APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product Offered
11.9.3 APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 APPLIED PROTEIN TECHNOLOGY Main Business Overview
11.9.5 APPLIED PROTEIN TECHNOLOGY Latest Developments
11.10 Suzhou PANOMIX Biomedical Tech Co.,Ltd
11.10.1 Suzhou PANOMIX Biomedical Tech Co.,Ltd Company Information
11.10.2 Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product Offered
11.10.3 Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Suzhou PANOMIX Biomedical Tech Co.,Ltd Main Business Overview
11.10.5 Suzhou PANOMIX Biomedical Tech Co.,Ltd Latest Developments
11.11 OBiO Technology ( Shanghai ) Corp.,Ltd.
11.11.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Company Information
11.11.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product Offered
11.11.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Main Business Overview
11.11.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Latest Developments
11.12 Beijing Huayi innovation & BioTechnology Co., Ltd
11.12.1 Beijing Huayi innovation & BioTechnology Co., Ltd Company Information
11.12.2 Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Product Offered
11.12.3 Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Beijing Huayi innovation & BioTechnology Co., Ltd Main Business Overview
11.12.5 Beijing Huayi innovation & BioTechnology Co., Ltd Latest Developments
11.13 Abace Biotechnology
11.13.1 Abace Biotechnology Company Information
11.13.2 Abace Biotechnology Untargeted Metabolomics Product Offered
11.13.3 Abace Biotechnology Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Abace Biotechnology Main Business Overview
11.13.5 Abace Biotechnology Latest Developments
11.14 Metabo-Profile
11.14.1 Metabo-Profile Company Information
11.14.2 Metabo-Profile Untargeted Metabolomics Product Offered
11.14.3 Metabo-Profile Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Metabo-Profile Main Business Overview
11.14.5 Metabo-Profile Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Untargeted Metabolomics Market Size (2021-2032)
2.1.2 Untargeted Metabolomics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Untargeted Metabolomics by Country/Region (2021, 2025 & 2032)
2.2 Untargeted Metabolomics Segment by Type
2.2.1 Plant Untargeted Metabolomics
2.2.2 Human Untargeted Metabolomics
2.2.3 Other
2.2.4 Untargeted Metabolomics Market Size by Type
2.2.4.1 Untargeted Metabolomics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Untargeted Metabolomics Market Size Market Share by Type (2021-2026)
2.3 Untargeted Metabolomics Segment by Application
2.3.1 Academic and Research Institutions
2.3.2 Pharmaceutical and Biotechnology Companies
2.3.3 Untargeted Metabolomics Market Size by Application
2.3.3.1 Untargeted Metabolomics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Untargeted Metabolomics Market Size Market Share by Application (2021-2026)
3 UNTARGETED METABOLOMICS MARKET SIZE BY PLAYER
3.1 Untargeted Metabolomics Market Size Market Share by Player
3.1.1 Global Untargeted Metabolomics Revenue by Player (2021-2026)
3.1.2 Global Untargeted Metabolomics Revenue Market Share by Player (2021-2026)
3.2 Global Untargeted Metabolomics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 UNTARGETED METABOLOMICS BY REGION
4.1 Untargeted Metabolomics Market Size by Region (2021-2026)
4.2 Global Untargeted Metabolomics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Untargeted Metabolomics Market Size Growth (2021-2026)
4.4 APAC Untargeted Metabolomics Market Size Growth (2021-2026)
4.5 Europe Untargeted Metabolomics Market Size Growth (2021-2026)
4.6 Middle East & Africa Untargeted Metabolomics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Untargeted Metabolomics Market Size by Country (2021-2026)
5.2 Americas Untargeted Metabolomics Market Size by Type (2021-2026)
5.3 Americas Untargeted Metabolomics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Untargeted Metabolomics Market Size by Region (2021-2026)
6.2 APAC Untargeted Metabolomics Market Size by Type (2021-2026)
6.3 APAC Untargeted Metabolomics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Untargeted Metabolomics Market Size by Country (2021-2026)
7.2 Europe Untargeted Metabolomics Market Size by Type (2021-2026)
7.3 Europe Untargeted Metabolomics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Untargeted Metabolomics by Region (2021-2026)
8.2 Middle East & Africa Untargeted Metabolomics Market Size by Type (2021-2026)
8.3 Middle East & Africa Untargeted Metabolomics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL UNTARGETED METABOLOMICS MARKET FORECAST
10.1 Global Untargeted Metabolomics Forecast by Region (2027-2032)
10.1.1 Global Untargeted Metabolomics Forecast by Region (2027-2032)
10.1.2 Americas Untargeted Metabolomics Forecast
10.1.3 APAC Untargeted Metabolomics Forecast
10.1.4 Europe Untargeted Metabolomics Forecast
10.1.5 Middle East & Africa Untargeted Metabolomics Forecast
10.2 Americas Untargeted Metabolomics Forecast by Country (2027-2032)
10.2.1 United States Market Untargeted Metabolomics Forecast
10.2.2 Canada Market Untargeted Metabolomics Forecast
10.2.3 Mexico Market Untargeted Metabolomics Forecast
10.2.4 Brazil Market Untargeted Metabolomics Forecast
10.3 APAC Untargeted Metabolomics Forecast by Region (2027-2032)
10.3.1 China Untargeted Metabolomics Market Forecast
10.3.2 Japan Market Untargeted Metabolomics Forecast
10.3.3 Korea Market Untargeted Metabolomics Forecast
10.3.4 Southeast Asia Market Untargeted Metabolomics Forecast
10.3.5 India Market Untargeted Metabolomics Forecast
10.3.6 Australia Market Untargeted Metabolomics Forecast
10.4 Europe Untargeted Metabolomics Forecast by Country (2027-2032)
10.4.1 Germany Market Untargeted Metabolomics Forecast
10.4.2 France Market Untargeted Metabolomics Forecast
10.4.3 UK Market Untargeted Metabolomics Forecast
10.4.4 Italy Market Untargeted Metabolomics Forecast
10.4.5 Russia Market Untargeted Metabolomics Forecast
10.5 Middle East & Africa Untargeted Metabolomics Forecast by Region (2027-2032)
10.5.1 Egypt Market Untargeted Metabolomics Forecast
10.5.2 South Africa Market Untargeted Metabolomics Forecast
10.5.3 Israel Market Untargeted Metabolomics Forecast
10.5.4 Turkey Market Untargeted Metabolomics Forecast
10.6 Global Untargeted Metabolomics Forecast by Type (2027-2032)
10.7 Global Untargeted Metabolomics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Untargeted Metabolomics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Creative Proteomics
11.1.1 Creative Proteomics Company Information
11.1.2 Creative Proteomics Untargeted Metabolomics Product Offered
11.1.3 Creative Proteomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Creative Proteomics Main Business Overview
11.1.5 Creative Proteomics Latest Developments
11.2 Metabolon
11.2.1 Metabolon Company Information
11.2.2 Metabolon Untargeted Metabolomics Product Offered
11.2.3 Metabolon Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Metabolon Main Business Overview
11.2.5 Metabolon Latest Developments
11.3 Alfa Chemistry
11.3.1 Alfa Chemistry Company Information
11.3.2 Alfa Chemistry Untargeted Metabolomics Product Offered
11.3.3 Alfa Chemistry Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Alfa Chemistry Main Business Overview
11.3.5 Alfa Chemistry Latest Developments
11.4 Novelgene Technologies
11.4.1 Novelgene Technologies Company Information
11.4.2 Novelgene Technologies Untargeted Metabolomics Product Offered
11.4.3 Novelgene Technologies Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Novelgene Technologies Main Business Overview
11.4.5 Novelgene Technologies Latest Developments
11.5 MtoZ-Biolabs Inc.
11.5.1 MtoZ-Biolabs Inc. Company Information
11.5.2 MtoZ-Biolabs Inc. Untargeted Metabolomics Product Offered
11.5.3 MtoZ-Biolabs Inc. Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 MtoZ-Biolabs Inc. Main Business Overview
11.5.5 MtoZ-Biolabs Inc. Latest Developments
11.6 CD Genomics
11.6.1 CD Genomics Company Information
11.6.2 CD Genomics Untargeted Metabolomics Product Offered
11.6.3 CD Genomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 CD Genomics Main Business Overview
11.6.5 CD Genomics Latest Developments
11.7 Metware Biotechnology Inc (Metware)
11.7.1 Metware Biotechnology Inc (Metware) Company Information
11.7.2 Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product Offered
11.7.3 Metware Biotechnology Inc (Metware) Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Metware Biotechnology Inc (Metware) Main Business Overview
11.7.5 Metware Biotechnology Inc (Metware) Latest Developments
11.8 BGI Genomics
11.8.1 BGI Genomics Company Information
11.8.2 BGI Genomics Untargeted Metabolomics Product Offered
11.8.3 BGI Genomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 BGI Genomics Main Business Overview
11.8.5 BGI Genomics Latest Developments
11.9 APPLIED PROTEIN TECHNOLOGY
11.9.1 APPLIED PROTEIN TECHNOLOGY Company Information
11.9.2 APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product Offered
11.9.3 APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 APPLIED PROTEIN TECHNOLOGY Main Business Overview
11.9.5 APPLIED PROTEIN TECHNOLOGY Latest Developments
11.10 Suzhou PANOMIX Biomedical Tech Co.,Ltd
11.10.1 Suzhou PANOMIX Biomedical Tech Co.,Ltd Company Information
11.10.2 Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product Offered
11.10.3 Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Suzhou PANOMIX Biomedical Tech Co.,Ltd Main Business Overview
11.10.5 Suzhou PANOMIX Biomedical Tech Co.,Ltd Latest Developments
11.11 OBiO Technology ( Shanghai ) Corp.,Ltd.
11.11.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Company Information
11.11.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product Offered
11.11.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Main Business Overview
11.11.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Latest Developments
11.12 Beijing Huayi innovation & BioTechnology Co., Ltd
11.12.1 Beijing Huayi innovation & BioTechnology Co., Ltd Company Information
11.12.2 Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Product Offered
11.12.3 Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Beijing Huayi innovation & BioTechnology Co., Ltd Main Business Overview
11.12.5 Beijing Huayi innovation & BioTechnology Co., Ltd Latest Developments
11.13 Abace Biotechnology
11.13.1 Abace Biotechnology Company Information
11.13.2 Abace Biotechnology Untargeted Metabolomics Product Offered
11.13.3 Abace Biotechnology Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Abace Biotechnology Main Business Overview
11.13.5 Abace Biotechnology Latest Developments
11.14 Metabo-Profile
11.14.1 Metabo-Profile Company Information
11.14.2 Metabo-Profile Untargeted Metabolomics Product Offered
11.14.3 Metabo-Profile Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Metabo-Profile Main Business Overview
11.14.5 Metabo-Profile Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Untargeted Metabolomics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Untargeted Metabolomics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Plant Untargeted Metabolomics
Table 4. Major Players of Human Untargeted Metabolomics
Table 5. Major Players of Other
Table 6. Untargeted Metabolomics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Untargeted Metabolomics Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Untargeted Metabolomics Market Size Market Share by Type (2021-2026)
Table 9. Untargeted Metabolomics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Untargeted Metabolomics Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Untargeted Metabolomics Market Size Market Share by Application (2021-2026)
Table 12. Global Untargeted Metabolomics Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Untargeted Metabolomics Revenue Market Share by Player (2021-2026)
Table 14. Untargeted Metabolomics Key Players Head office and Products Offered
Table 15. Untargeted Metabolomics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Untargeted Metabolomics Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Untargeted Metabolomics Market Size Market Share by Region (2021-2026)
Table 20. Global Untargeted Metabolomics Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Untargeted Metabolomics Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Untargeted Metabolomics Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Untargeted Metabolomics Market Size Market Share by Country (2021-2026)
Table 24. Americas Untargeted Metabolomics Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Untargeted Metabolomics Market Size Market Share by Type (2021-2026)
Table 26. Americas Untargeted Metabolomics Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Untargeted Metabolomics Market Size Market Share by Application (2021-2026)
Table 28. APAC Untargeted Metabolomics Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Untargeted Metabolomics Market Size Market Share by Region (2021-2026)
Table 30. APAC Untargeted Metabolomics Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Untargeted Metabolomics Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Untargeted Metabolomics Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Untargeted Metabolomics Market Size Market Share by Country (2021-2026)
Table 34. Europe Untargeted Metabolomics Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Untargeted Metabolomics Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Untargeted Metabolomics Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Untargeted Metabolomics Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Untargeted Metabolomics Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Untargeted Metabolomics
Table 40. Key Market Challenges & Risks of Untargeted Metabolomics
Table 41. Key Industry Trends of Untargeted Metabolomics
Table 42. Global Untargeted Metabolomics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Untargeted Metabolomics Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Untargeted Metabolomics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Untargeted Metabolomics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Creative Proteomics Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 47. Creative Proteomics Untargeted Metabolomics Product Offered
Table 48. Creative Proteomics Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Creative Proteomics Main Business
Table 50. Creative Proteomics Latest Developments
Table 51. Metabolon Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 52. Metabolon Untargeted Metabolomics Product Offered
Table 53. Metabolon Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Metabolon Main Business
Table 55. Metabolon Latest Developments
Table 56. Alfa Chemistry Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 57. Alfa Chemistry Untargeted Metabolomics Product Offered
Table 58. Alfa Chemistry Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Alfa Chemistry Main Business
Table 60. Alfa Chemistry Latest Developments
Table 61. Novelgene Technologies Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 62. Novelgene Technologies Untargeted Metabolomics Product Offered
Table 63. Novelgene Technologies Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Novelgene Technologies Main Business
Table 65. Novelgene Technologies Latest Developments
Table 66. MtoZ-Biolabs Inc. Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 67. MtoZ-Biolabs Inc. Untargeted Metabolomics Product Offered
Table 68. MtoZ-Biolabs Inc. Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. MtoZ-Biolabs Inc. Main Business
Table 70. MtoZ-Biolabs Inc. Latest Developments
Table 71. CD Genomics Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 72. CD Genomics Untargeted Metabolomics Product Offered
Table 73. CD Genomics Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. CD Genomics Main Business
Table 75. CD Genomics Latest Developments
Table 76. Metware Biotechnology Inc (Metware) Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 77. Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product Offered
Table 78. Metware Biotechnology Inc (Metware) Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Metware Biotechnology Inc (Metware) Main Business
Table 80. Metware Biotechnology Inc (Metware) Latest Developments
Table 81. BGI Genomics Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 82. BGI Genomics Untargeted Metabolomics Product Offered
Table 83. BGI Genomics Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. BGI Genomics Main Business
Table 85. BGI Genomics Latest Developments
Table 86. APPLIED PROTEIN TECHNOLOGY Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 87. APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product Offered
Table 88. APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. APPLIED PROTEIN TECHNOLOGY Main Business
Table 90. APPLIED PROTEIN TECHNOLOGY Latest Developments
Table 91. Suzhou PANOMIX Biomedical Tech Co.,Ltd Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 92. Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product Offered
Table 93. Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Suzhou PANOMIX Biomedical Tech Co.,Ltd Main Business
Table 95. Suzhou PANOMIX Biomedical Tech Co.,Ltd Latest Developments
Table 96. OBiO Technology ( Shanghai ) Corp.,Ltd. Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 97. OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product Offered
Table 98. OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. OBiO Technology ( Shanghai ) Corp.,Ltd. Main Business
Table 100. OBiO Technology ( Shanghai ) Corp.,Ltd. Latest Developments
Table 101. Beijing Huayi innovation & BioTechnology Co., Ltd Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 102. Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Product Offered
Table 103. Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Beijing Huayi innovation & BioTechnology Co., Ltd Main Business
Table 105. Beijing Huayi innovation & BioTechnology Co., Ltd Latest Developments
Table 106. Abace Biotechnology Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 107. Abace Biotechnology Untargeted Metabolomics Product Offered
Table 108. Abace Biotechnology Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Abace Biotechnology Main Business
Table 110. Abace Biotechnology Latest Developments
Table 111. Metabo-Profile Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 112. Metabo-Profile Untargeted Metabolomics Product Offered
Table 113. Metabo-Profile Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Metabo-Profile Main Business
Table 115. Metabo-Profile Latest Developments
Table 1. Untargeted Metabolomics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Untargeted Metabolomics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Plant Untargeted Metabolomics
Table 4. Major Players of Human Untargeted Metabolomics
Table 5. Major Players of Other
Table 6. Untargeted Metabolomics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Untargeted Metabolomics Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Untargeted Metabolomics Market Size Market Share by Type (2021-2026)
Table 9. Untargeted Metabolomics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Untargeted Metabolomics Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Untargeted Metabolomics Market Size Market Share by Application (2021-2026)
Table 12. Global Untargeted Metabolomics Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Untargeted Metabolomics Revenue Market Share by Player (2021-2026)
Table 14. Untargeted Metabolomics Key Players Head office and Products Offered
Table 15. Untargeted Metabolomics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Untargeted Metabolomics Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Untargeted Metabolomics Market Size Market Share by Region (2021-2026)
Table 20. Global Untargeted Metabolomics Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Untargeted Metabolomics Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Untargeted Metabolomics Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Untargeted Metabolomics Market Size Market Share by Country (2021-2026)
Table 24. Americas Untargeted Metabolomics Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Untargeted Metabolomics Market Size Market Share by Type (2021-2026)
Table 26. Americas Untargeted Metabolomics Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Untargeted Metabolomics Market Size Market Share by Application (2021-2026)
Table 28. APAC Untargeted Metabolomics Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Untargeted Metabolomics Market Size Market Share by Region (2021-2026)
Table 30. APAC Untargeted Metabolomics Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Untargeted Metabolomics Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Untargeted Metabolomics Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Untargeted Metabolomics Market Size Market Share by Country (2021-2026)
Table 34. Europe Untargeted Metabolomics Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Untargeted Metabolomics Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Untargeted Metabolomics Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Untargeted Metabolomics Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Untargeted Metabolomics Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Untargeted Metabolomics
Table 40. Key Market Challenges & Risks of Untargeted Metabolomics
Table 41. Key Industry Trends of Untargeted Metabolomics
Table 42. Global Untargeted Metabolomics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Untargeted Metabolomics Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Untargeted Metabolomics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Untargeted Metabolomics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Creative Proteomics Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 47. Creative Proteomics Untargeted Metabolomics Product Offered
Table 48. Creative Proteomics Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Creative Proteomics Main Business
Table 50. Creative Proteomics Latest Developments
Table 51. Metabolon Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 52. Metabolon Untargeted Metabolomics Product Offered
Table 53. Metabolon Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Metabolon Main Business
Table 55. Metabolon Latest Developments
Table 56. Alfa Chemistry Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 57. Alfa Chemistry Untargeted Metabolomics Product Offered
Table 58. Alfa Chemistry Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Alfa Chemistry Main Business
Table 60. Alfa Chemistry Latest Developments
Table 61. Novelgene Technologies Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 62. Novelgene Technologies Untargeted Metabolomics Product Offered
Table 63. Novelgene Technologies Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Novelgene Technologies Main Business
Table 65. Novelgene Technologies Latest Developments
Table 66. MtoZ-Biolabs Inc. Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 67. MtoZ-Biolabs Inc. Untargeted Metabolomics Product Offered
Table 68. MtoZ-Biolabs Inc. Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. MtoZ-Biolabs Inc. Main Business
Table 70. MtoZ-Biolabs Inc. Latest Developments
Table 71. CD Genomics Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 72. CD Genomics Untargeted Metabolomics Product Offered
Table 73. CD Genomics Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. CD Genomics Main Business
Table 75. CD Genomics Latest Developments
Table 76. Metware Biotechnology Inc (Metware) Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 77. Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product Offered
Table 78. Metware Biotechnology Inc (Metware) Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Metware Biotechnology Inc (Metware) Main Business
Table 80. Metware Biotechnology Inc (Metware) Latest Developments
Table 81. BGI Genomics Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 82. BGI Genomics Untargeted Metabolomics Product Offered
Table 83. BGI Genomics Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. BGI Genomics Main Business
Table 85. BGI Genomics Latest Developments
Table 86. APPLIED PROTEIN TECHNOLOGY Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 87. APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product Offered
Table 88. APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. APPLIED PROTEIN TECHNOLOGY Main Business
Table 90. APPLIED PROTEIN TECHNOLOGY Latest Developments
Table 91. Suzhou PANOMIX Biomedical Tech Co.,Ltd Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 92. Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product Offered
Table 93. Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Suzhou PANOMIX Biomedical Tech Co.,Ltd Main Business
Table 95. Suzhou PANOMIX Biomedical Tech Co.,Ltd Latest Developments
Table 96. OBiO Technology ( Shanghai ) Corp.,Ltd. Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 97. OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product Offered
Table 98. OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. OBiO Technology ( Shanghai ) Corp.,Ltd. Main Business
Table 100. OBiO Technology ( Shanghai ) Corp.,Ltd. Latest Developments
Table 101. Beijing Huayi innovation & BioTechnology Co., Ltd Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 102. Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Product Offered
Table 103. Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Beijing Huayi innovation & BioTechnology Co., Ltd Main Business
Table 105. Beijing Huayi innovation & BioTechnology Co., Ltd Latest Developments
Table 106. Abace Biotechnology Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 107. Abace Biotechnology Untargeted Metabolomics Product Offered
Table 108. Abace Biotechnology Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Abace Biotechnology Main Business
Table 110. Abace Biotechnology Latest Developments
Table 111. Metabo-Profile Details, Company Type, Untargeted Metabolomics Area Served and Its Competitors
Table 112. Metabo-Profile Untargeted Metabolomics Product Offered
Table 113. Metabo-Profile Untargeted Metabolomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Metabo-Profile Main Business
Table 115. Metabo-Profile Latest Developments
LIST OF FIGURES
Figure 1. Untargeted Metabolomics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Untargeted Metabolomics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Untargeted Metabolomics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Untargeted Metabolomics Sales Market Share by Country/Region (2025)
Figure 8. Untargeted Metabolomics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Untargeted Metabolomics Market Size Market Share by Type in 2025
Figure 10. Untargeted Metabolomics in Academic and Research Institutions
Figure 11. Global Untargeted Metabolomics Market: Academic and Research Institutions (2021-2026) & ($ millions)
Figure 12. Untargeted Metabolomics in Pharmaceutical and Biotechnology Companies
Figure 13. Global Untargeted Metabolomics Market: Pharmaceutical and Biotechnology Companies (2021-2026) & ($ millions)
Figure 14. Global Untargeted Metabolomics Market Size Market Share by Application in 2025
Figure 15. Global Untargeted Metabolomics Revenue Market Share by Player in 2025
Figure 16. Global Untargeted Metabolomics Market Size Market Share by Region (2021-2026)
Figure 17. Americas Untargeted Metabolomics Market Size 2021-2026 ($ millions)
Figure 18. APAC Untargeted Metabolomics Market Size 2021-2026 ($ millions)
Figure 19. Europe Untargeted Metabolomics Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Untargeted Metabolomics Market Size 2021-2026 ($ millions)
Figure 21. Americas Untargeted Metabolomics Value Market Share by Country in 2025
Figure 22. United States Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Untargeted Metabolomics Market Size Market Share by Region in 2025
Figure 27. APAC Untargeted Metabolomics Market Size Market Share by Type (2021-2026)
Figure 28. APAC Untargeted Metabolomics Market Size Market Share by Application (2021-2026)
Figure 29. China Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 33. India Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Untargeted Metabolomics Market Size Market Share by Country in 2025
Figure 36. Europe Untargeted Metabolomics Market Size Market Share by Type (2021-2026)
Figure 37. Europe Untargeted Metabolomics Market Size Market Share by Application (2021-2026)
Figure 38. Germany Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 39. France Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Untargeted Metabolomics Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Untargeted Metabolomics Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Untargeted Metabolomics Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 52. APAC Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 53. Europe Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 55. United States Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 56. Canada Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 57. Mexico Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 58. Brazil Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 59. China Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 60. Japan Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 61. Korea Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 63. India Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 64. Australia Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 65. Germany Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 66. France Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 67. UK Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 68. Italy Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 69. Russia Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 70. Egypt Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 71. South Africa Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 72. Israel Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 73. Turkey Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 74. Global Untargeted Metabolomics Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Untargeted Metabolomics Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 1. Untargeted Metabolomics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Untargeted Metabolomics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Untargeted Metabolomics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Untargeted Metabolomics Sales Market Share by Country/Region (2025)
Figure 8. Untargeted Metabolomics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Untargeted Metabolomics Market Size Market Share by Type in 2025
Figure 10. Untargeted Metabolomics in Academic and Research Institutions
Figure 11. Global Untargeted Metabolomics Market: Academic and Research Institutions (2021-2026) & ($ millions)
Figure 12. Untargeted Metabolomics in Pharmaceutical and Biotechnology Companies
Figure 13. Global Untargeted Metabolomics Market: Pharmaceutical and Biotechnology Companies (2021-2026) & ($ millions)
Figure 14. Global Untargeted Metabolomics Market Size Market Share by Application in 2025
Figure 15. Global Untargeted Metabolomics Revenue Market Share by Player in 2025
Figure 16. Global Untargeted Metabolomics Market Size Market Share by Region (2021-2026)
Figure 17. Americas Untargeted Metabolomics Market Size 2021-2026 ($ millions)
Figure 18. APAC Untargeted Metabolomics Market Size 2021-2026 ($ millions)
Figure 19. Europe Untargeted Metabolomics Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Untargeted Metabolomics Market Size 2021-2026 ($ millions)
Figure 21. Americas Untargeted Metabolomics Value Market Share by Country in 2025
Figure 22. United States Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Untargeted Metabolomics Market Size Market Share by Region in 2025
Figure 27. APAC Untargeted Metabolomics Market Size Market Share by Type (2021-2026)
Figure 28. APAC Untargeted Metabolomics Market Size Market Share by Application (2021-2026)
Figure 29. China Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 33. India Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Untargeted Metabolomics Market Size Market Share by Country in 2025
Figure 36. Europe Untargeted Metabolomics Market Size Market Share by Type (2021-2026)
Figure 37. Europe Untargeted Metabolomics Market Size Market Share by Application (2021-2026)
Figure 38. Germany Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 39. France Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Untargeted Metabolomics Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Untargeted Metabolomics Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Untargeted Metabolomics Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Untargeted Metabolomics Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 52. APAC Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 53. Europe Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 55. United States Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 56. Canada Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 57. Mexico Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 58. Brazil Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 59. China Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 60. Japan Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 61. Korea Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 63. India Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 64. Australia Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 65. Germany Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 66. France Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 67. UK Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 68. Italy Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 69. Russia Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 70. Egypt Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 71. South Africa Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 72. Israel Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 73. Turkey Untargeted Metabolomics Market Size 2027-2032 ($ millions)
Figure 74. Global Untargeted Metabolomics Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Untargeted Metabolomics Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Untargeted Metabolomics Market Size 2027-2032 ($ millions)
